Encephalitis, Japanese B Completed Phase 4 Trials for Japanese encephalitis vaccine (live, attenuated) (DB16577)
Also known as: Japanese Encephalitis / Encephalitis, Japanese / Encephalitis Japanese B / Japanese Encephalitis Virus Disease / Japanese B encephalitis / Japanese B viral encephalitis / Japanese encephalitis virus disease (disorder) / Arthropod-borne viral disease (& [dengue] or [Japanese encephalitis] or [yellow fever])
Indication | Status | Phase |
---|---|---|
DBCOND0033957 (Encephalitis, Japanese B) | Completed | 4 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02514746 | Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose | Prevention | |
NCT02880865 | Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine | Prevention | |
NCT01981967 | Post-licensure Safety Study of IMOJEVĀ® in Thailand | Prevention |